Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8


Regulation of human helper T cell subset differentiation by cytokines.

Schmitt N, Ueno H.

Curr Opin Immunol. 2015 Jun;34:130-6. doi: 10.1016/j.coi.2015.03.007. Epub 2015 Apr 11. Review.


Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.

Tandon R, Chew GM, Byron MM, Borrow P, Niki T, Hirashima M, Barbour JD, Norris PJ, Lanteri MC, Martin JN, Deeks SG, Ndhlovu LC.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):654-64. doi: 10.1089/AID.2014.0004. Epub 2014 May 28.


Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG.

PLoS Pathog. 2013;9(5):e1003347. doi: 10.1371/journal.ppat.1003347. Epub 2013 May 9.


Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.

Leal FE, Ndhlovu LC, Hasenkrug AM, Bruno FR, Carvalho KI, Wynn-Williams H, Neto WK, Sanabani SS, Segurado AC, Nixon DF, Kallas EG.

PLoS Negl Trop Dis. 2013;7(2):e2028. doi: 10.1371/journal.pntd.0002028. Epub 2013 Feb 7.


Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Liao W, Lin JX, Leonard WJ.

Immunity. 2013 Jan 24;38(1):13-25. doi: 10.1016/j.immuni.2013.01.004. Review.


In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines.

Alvarez Y, Tuen M, Nàdas A, Hioe CE.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):823-34. doi: 10.1089/AID.2011.0184. Epub 2011 Dec 1.


Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.

Burton CT, Westrop SJ, Eccles-James I, Boasso A, Nelson MR, Bower M, Imami N.

Clin Exp Immunol. 2011 Nov;166(2):191-200. doi: 10.1111/j.1365-2249.2011.04451.x.


Regulatory T cells in HIV immunotherapy.

Macatangay BJ, Rinaldo CR.

HIV Ther. 2010 Nov;4(6):639-647.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk